Market Cap

Myriad Genetics, Inc. Market Capitalization:

$1.58 Billion

USD as of Jan. 1, 2024

business Myriad Genetics, Inc. Company Profile

Myriad Genetics, Inc. Main Stock Listing

NASDAQ: MYGN

Market Capitalization History of Myriad Genetics, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Diagnostics & Research
Company Market Cap (USD)
Thermo Fisher Scientific $207.62 B
Danaher $171.89 B
Siemens Healthineers AG $66.05 B
DexCom, Inc. $46.50 B
IDEXX Laboratories, Inc. $44.72 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Myriad Genetics, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2024 $1.58 B 7.08%
Jan. 1, 2023 $1.47 B -32.67%
Jan. 1, 2022 $2.19 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Myriad Genetics, Inc. Categories

United States languages Healthcare languages Diagnostics & Research
United States Healthcare United States Diagnostics & Research

Stocks & Indices

Myriad Genetics, Inc. has the following listings and related stock indices.


Stock: NASDAQ: MYGN

Stock: FSX: MYD

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.